<div id="readability-page-1"><div><p><span>CARsgen Therapeutics Holdings Ltd </span><span>:</span></p><ul><li>NET LOSS EXPECTED TO REDUCE TO UP TO RMB120 MILLION IN FY</li><li>LOSS REDUCTION DUE TO INCREASED REVENUES FROM ZEVORCABTAGENE AUTOLEUCEL, OTHERS IN FY</li></ul></div></div>

<p>CARsgen Therapeutics Holdings Ltd :NET LOSS EXPECTED TO REDUCE TO UP TO RMB120 MILLION IN FYLOSS REDUCTION DUE TO INCREASED REVENUES FROM ZEVORCABTAGENE AUTOLEUCEL, OTHERS IN FY</p>

Reuters

iShares Biotechnology ETF

Penghua CSI HK Connect Health Care Composite ETF

ChinaAMC SSE Health Care ETF Initiating Fund

Hwabao WP CSI Medical Service ETF

Invesco Nasdaq Biotechnology ETF

VanEck Biotech ETF

China Merchants CSI Biotechnology Theme ETF

China Southern Hang Seng Biotech ETF(QDII)

ALPS Medical Breakthrough

Invesco Biotechnology & Genome ETF

SPDR S&P Biotech

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

Yinhua CSI Research Sector 100 ETF

CARSGEN-B

Ping An CSI Medicine and Medical Device Innovation ETF

GF CSI HK Innovative Drugs Industry ETF(QDII)

Penghua SSE STAR Biology and Medicine ETF

Guotai CSI Bio-medicine ETF

ChinaAMC CSI Biotechnology Theme ETF

Yinhua CSI Innovative Drugs Industry ETF

Minsheng Royal CSI Biotechnology Theme ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

Founder Fubon CSI Medicine and Medical Device Innovation ETF

Proshares Ultra Nasdaq Biotech

Huaan Hang Seng Biotech ETF

Coeptis Therapeutics

E Fund Hang Seng SCHK Innovative Drug ETF

Genocea Biosciences

Bosera Hang Seng Health Care ETF(QDII)

Direxion S&P Biotech Bear 3X

ChinaAMC SSE STAR Biology and Medicine ETF

Ark Genomic Revolution ETF

E Fund CSI Biotechnology Theme ETF

Genetic Technologies Limited

E Fund CSI 300 Health Care ETF

First Trust NYSE Arca Biotech Index Fd

Tianhong CNI BIOMEDICINE ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

Carsgen Therapeutics Sees FY Net Loss Of Up To RMB120 MLN